Epidemiology of clinically significant migraine in Israel: a retrospective database study
This study provides a detailed epidemiological and clinical profile of patients with clinically significant migraine in LHS from 2017 to 2022. Notable trends include higher rates of migraine among patients with lower BMI, higher diastolic BP, lower glucose, and higher hemoglobin, suggesting potential modifiable risk factors.
Authors
- Shlomo Vinker (ORCID: https://orcid.org/0000-0001-9804-7103)
- Matanya Tirosh
- Ariel Israel (ORCID: https://orcid.org/0000-0003-4389-8896)
- Eytan Domany
- Itay Forschner
- Danna Davidovici
- Alla Shifrin
Institutions
- Tel Aviv University (IL)
- Rambam Health Care Campus (IL)
- Advanced Inhalation Therapies (Israel) (IL)
- ORASIS Pharmaceuticals (Israel) (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1186/s10194-025-01961-0
- Citations
- 6
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.83
Funders
- Pfizer
- Pfizer Pharmaceuticals